Nature Cancer March issue cover.

The pleiotropic functions of reactive oxygen species in cancer

  • Katherine Wu
  • Ahmed Ezat El Zowalaty
  • Thales Papagiannakopoulos
Review Article

Announcements

  • Microscopy image of colorized immune cells.

    Join us for a Nature Conference on cancer immunotherapy, co-organized by Dana Farber Cancer Institute, Nature Cancer, Nature Immunology, Nature Medicine and Nature Immunology on June 10-12 2024 in Boston. Submit your abstract by April 12, 2024.

  • Nature Cancer December issue cover

    We bid farewell to 2023 with a Focus issue comprising news and comment articles on the biggest advances and challenges of the year and highlights from the published literature.

  • Nature Cancer pictorial

    View webcasts hosted by Nature Cancer editors, in which expert cancer researchers and clinicians discuss the most exciting advances and biggest challenges in their fields. Past events can be accessed on demand for free by registering your attendee details.

  • Image displaying the registration page for the conference

    Join us for a virtual meeting bringing together experts across disciplines to discuss developments in antigen discovery, preclinical vaccine development and clinical advances in cancer vaccine therapy, and reflect on the ongoing challenges and necessities in the field.

Nature Cancer is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

  • Johanna Joyce received her PhD from the University of Cambridge, and did postdoctoral research at the University of California, San Francisco. She then joined the faculty at Memorial Sloan Kettering Cancer Center, New York, becoming a tenured member in 2014. She moved to Switzerland in 2016, where she later served as the inaugural executive director of the Agora Cancer Center Lausanne. She is currently a member of the Ludwig Institute for Cancer Research and a professor at the University of Lausanne.

    • Johanna A. Joyce
    Turning Points
  • Gold-standard cancer data management is pivotal to enable precision medicine for European citizens. Achieving this goal relies on key elements: adopting standardized data formats, ensuring robust data privacy, educating professionals about the infrastructure’s benefits and leveraging cutting-edge technologies to transform cancer care.

    • Macha Nikolski
    • Eivind Hovig
    • Gary Saunders
    Comment
  • Drug regulatory agencies in the USA and Europe have mechanisms to provide patients faster access to novel treatments, expecting that follow-up trials will confirm clinically meaningful results. However, some early approvals are subsequently withdrawn. Here we discuss the insights gained from withdrawn accelerated approvals for oncologic agents in the past decade.

    • George S. Mellgard
    • Tito Fojo
    • Susan E. Bates
    Comment
  • Anirban Maitra obtained his medical degree from the All India Institute of Medical Sciences, New Delhi, in 1996; this was followed by residency and fellowships in pathology at the University of Texas Southwestern Medical Center, Dallas, and Johns Hopkins University School of Medicine, Baltimore. From 2002 to 2013, he served as faculty in the departments of pathology and oncology at Johns Hopkins, before being recruited to the MD Anderson Cancer Center as Professor of Pathology and Translational Molecular Pathology and Scientific Director of the Sheikh Ahmed Center for Pancreatic Cancer Research.

    • Anirban Maitra
    Turning Points
  • Rebecca Fitzgerald completed her medical degree at the University of Cambridge, followed by doctoral research at Stanford University, and then postdoctoral research alongside specialist training in gastroenterology at Barts and the London Hospitals. She started her own independent group the MRC Cancer Unit in 2001 with an honorary gastroenterology consultant position at Addenbrooke’s Hospital. In 2014, she was elected to chair in cancer prevention, and in 2022 inaugural director of the department of oncology at the Early Cancer Institute, University of Cambridge.

    • Rebecca Fitzgerald
    Turning Points

Nature Careers

Science jobs

  • World-Class Leaders for Research in Materials Science

    National Institute for Materials Science (NIMS, Japan) calls for outstanding researchers who can drive world-class research in materials science.

    Tsukuba, Japan (JP)

    National Institute for Materials Science

  • Professor of Experimental Parasitology (Leishmania)

    To develop an innovative and internationally competitive research program, to contribute to educational activities and to provide expert advice.

    Belgium (BE)

    Institute of Tropical Medicine

  • PhD Candidate (m/f/d)

    We search the candidate for the subproject "P2: targeting cardiac macrophages" as part of the DFG-funded Research Training Group "GRK 2989: Targeti...

    Dortmund, Nordrhein-Westfalen (DE)

    Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V.

  • PhD Candidate (m/f/d)

    At our location in Dortmund we invite applications for a DFG-funded project. This project will aim to structurally and spatially resolve the altere...

    Dortmund, Nordrhein-Westfalen (DE)

    Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V.

  • Postdoctoral Fellow

    We are seeking a highly motivated PhD and/or MD graduate to work in the Cardiovascular research lab in the Tulane University Department of Medicine.

    New Orleans, Louisiana

    School of Medicine Tulane University

Advertisement